Sanofi Genzyme

Latest articles

2d
Boston Globe
Sanofi Genzyme recalls arthritis medicine following surge in side effectsAbout 18,000 gel-filled syringes sold by the Cambridge biotech Sanofi Genzyme t
Boston Globe / Posted 2 days ago
About 18,000 gel-filled syringes sold by the Cambridge biotech Sanofi Genzyme to treat arthritis of the knee have been recalled because that batch was linked to a surge in side effects. Sanofi Genzyme informed doctors, pharmacists, and clinics... Read more
10d
Business Standard India
After new rare diseases policy, govt incentives needed for finding curesevery two weeks, and the treatment continues lifelong. A few pharmaceutical co
Business Standard India / Posted 10 days ago
every two weeks, and the treatment continues lifelong. A few pharmaceutical companies such as the US-headquartered Sanofi Genzyme and Ireland-based Shire offer charitable programmes, thanks to the efforts of ORDI and Delhi-based Lysosome... Read more
13d
Business Wire
Cerevance Appoints David H. Margolin, MD, PhD as Senior Vice President of Clinical and Translational Medicineof Clinical and Translational Medicine. Prior to joining Cerevance, Dr. Margoli
Business Wire / Posted 13 days ago
of Clinical and Translational Medicine. Prior to joining Cerevance, Dr. Margolin served in several leadership roles at Sanofi-Genzyme over a 14-year period. There, he leveraged his expertise in designing and leading translational medicine... Read more
20d
Business Wire
U.S. Food and Drug Administration (FDA) Grants Alnylam Breakthrough Therapy Designation (BTD) for Patisiran for the Treatment of Hereditary ATTR (hATTR) Amyloidosis with Polyneuropathyin the U.S., and was recently granted accelerated assessment by the European Me
Business Wire / Posted 20 days ago
in the U.S., and was recently granted accelerated assessment by the European Medicines Agency. Alnylam, in alliance with Sanofi Genzyme, intends to file a marketing authorization application in the European Union around year-end. “Hereditary... Read more

In this news